Atlas Trials

Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients

Clinical trial NCT06329674 · COMPLETED

Trial details

NCT number
NCT06329674
Sponsor
AJU Pharm Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type2 Diabetes
Start date
2021-04-27
Primary completion
2022-12-01
Enrollment
235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.